748826
Last Update Posted: 2015-09-03
Recruiting has ended
All Genders accepted | Under |
576 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Remicade Safety Line (Study P03236)(COMPLETED)
The goal of this study is to implement instruments that would increase the treating physician's awareness of the necessary tuberculosis screening when starting a new patient on infliximab (Remicade) therapy who has not reacted sufficiently to disease-modifying preparations, including methotrexate.
This study used a non-probability sampling method.
Eligibility
Relevant conditions:
Arthritis, Rheumatoid
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov